Kinled Holding key facts
- Kinled Holding is a family office based in Switzerland with 80 tracked portfolio companies.
- Notable positions include Shield AI, Saronic, Distalmotion.
- PrivateMarketView records 1 deal participation by Kinled Holding.
- Kinled Holding’s most recent recorded investment was in Jul 2023.
About Kinled Holding
Founded in 1924, Kinled is a family office investment firm based in Switzerland. The firm seeks to invest in the life sciences, digital technology, medical technology, biomedical technology, medical devices, biopharmaceuticals, healthcare services, and financial technology industries.
Investment activity
Kinled Holding has no recorded round in the last two years; its 1 recorded round dates from 2023 to Jul 2023. Most recently: OneTrust (Series D, Jul 2023).
Kinled Holding portfolio at a glance
80 portfolio companies are on record for Kinled Holding, including Shield AI, Saronic and Distalmotion.
43 of the 80 carry a recorded valuation and 3 have recorded secondary-market trades, the names a secondary buyer or seller can price.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 80 recorded positions
- ·Watchlist + alerts for Kinled Holding's activity
Portfolio
80 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Shield AI | Aerospace and Defense | ▮ | ▮ | ▮ |
| Saronic | Aerospace and Defense | ▮ | ▮ | ▮ |
| Distalmotion | — | ▮ | ▮ | ▮ |
+ 77 more companies · all 80, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Kinled Holding recent deals
1 recordedMembership and data by Private Market View
Frequently asked about Kinled Holding
- What companies does Kinled Holding invest in?
- Kinled Holding has 80 recorded portfolio companies, including Shield AI, Saronic, Distalmotion.
- Is Kinled Holding actively investing?
- Kinled Holding's most recent recorded investment was in Jul 2023.